ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 140 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,862,395 | -56.4% | 1,292,353 | -21.8% | 0.00% | -57.1% |
Q2 2023 | $15,748,668 | -10.1% | 1,652,536 | +3.7% | 0.01% | -22.2% |
Q1 2023 | $17,527,070 | +48.5% | 1,593,370 | +99.7% | 0.01% | +50.0% |
Q4 2022 | $11,806,493 | -22.7% | 797,736 | -0.2% | 0.01% | -25.0% |
Q3 2022 | $15,268,000 | -9.8% | 798,996 | +0.6% | 0.01% | 0.0% |
Q2 2022 | $16,918,000 | +33.1% | 793,896 | +20.3% | 0.01% | +60.0% |
Q1 2022 | $12,708,000 | -0.5% | 659,836 | +7.2% | 0.01% | 0.0% |
Q4 2021 | $12,771,000 | -7.1% | 615,745 | +7.0% | 0.01% | 0.0% |
Q3 2021 | $13,741,000 | -12.5% | 575,208 | -0.1% | 0.01% | -16.7% |
Q2 2021 | $15,712,000 | -16.8% | 575,728 | -11.8% | 0.01% | -25.0% |
Q1 2021 | $18,892,000 | – | 653,008 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 8,684,232 | $95,526,552 | 6.92% |
Bain Capital Life Sciences Investors, LLC | 3,000,000 | $33,000 | 4.12% |
Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $6,259,451 | 2.58% |
Opaleye Management Inc. | 502,000 | $5,522,000 | 1.65% |
1492 Capital Management LLC | 223,516 | $2,458,676 | 1.52% |
MIRABELLA FINANCIAL SERVICES LLP | 45,299 | $9,849,004 | 1.49% |
Saturn V Capital Management LP | 178,217 | $1,960,387 | 1.46% |
AlphaCentric Advisors LLC | 190,000 | $2,090,000 | 1.44% |
Rubric Capital Management LP | 3,500,000 | $38,500,000 | 1.00% |
MPM BioImpact LLC | 254,137 | $2,795,507 | 0.73% |